When is the Papilloma Virus Screening recommended?

Screening is recommended for:

  • women between the ages of 20 and 25, by carrying out the liquid or traditional Pap Test; for women aged 30–35 and over, by carrying out the HPV DNA Test;
  • women who test positive on the Pap Test, for whom screening and typing of the Papilloma virus with the HPV DNA Test is required.

What is papilloma virus?

Papilloma virus is one of the main causes of sexually transmitted infections and is the main risk factor for cervical cancer: the strains with a high oncogenic risk HPV16 and HPV18 are responsible for 70% of cases. 

The liquid-phase Pap Test is a cytological examination which was developed from the traditional Pap Test, by improving the representativeness of the cytological sample collected and the quality of the analysis. The cells are collected in a storage liquid, mechanically separated from materials which can interfere with the analysis, such as blood, debris and mucus, and placed in a single layer on a slide. 

The HPV DNA Test allows for more effective screening than the Pap Test for the prevention of cervical cancer. The test consists of screening and genotyping the virus. The Pap Test is recommended for women under 30 years of age.

How is the Papilloma Virus Screening carried out?

The Pap Test and HPV DNA Test require a cervical swab to collect cells from the uterine cervix.

Where is Papilloma Virus Screening done?

Papilloma Virus Screening can be carried out in all Lifebrain centres Find your nearest Lifebrain centre on www.lifebrain.it